Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.

MLA

Matsuzaki Tada, Asuka, et al. “Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.” Journal of Alzheimer’s Disease : JAD, vol. 89, no. 3, 2022, pp. 835–48. EBSCOhost, https://doi.org/10.3233/JAD-220192.

APA

Matsuzaki Tada, A., Hamezah, H. S., Pahrudin Arrozi, A., Abu Bakar, Z. H., Yanagisawa, D., & Tooyama, I. (2022). Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice. Journal of Alzheimer’s Disease : JAD, 89(3), 835–848. https://doi.org/10.3233/JAD-220192

Chicago

Matsuzaki Tada, Asuka, Hamizah Shahirah Hamezah, Aslina Pahrudin Arrozi, Zulzikry Hafiz Abu Bakar, Daijiro Yanagisawa, and Ikuo Tooyama. 2022. “Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.” Journal of Alzheimer’s Disease : JAD 89 (3): 835–48. doi:10.3233/JAD-220192.